IMM 0.00% 27.0¢ immutep limited

immunocellular therapies- good read

  1. 1,211 Posts.
    lightbulb Created with Sketch. 50
    Newly released article on another company in the immunotherapy field.

    http://seekingalpha.com/article/309610-immunocellular-the-potential-for-a-cancer-vaccine

    Although the momentum has been lost for PRR recently due to market sentiment the feeling I get from all the articles and news about the field of immunotherapy is the sentiment is strongly favourable for the sector for those with a long term perspective.

    For example the phase I trial results for ICT107 being described as "we think it’s a real phenomenon," "So I think what we’re seeing is really some pretty amazing outcomes,"

    The risk reward ratio in the cancer immunotherapy sector is gradually swinging toward the reward IMHO.

    Holding grimly.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
27.0¢
Change
0.000(0.00%)
Mkt cap ! $392.7M
Open High Low Value Volume
27.5¢ 27.5¢ 27.0¢ $67.07K 244.8K

Buyers (Bids)

No. Vol. Price($)
11 853767 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 141250 12
View Market Depth
Last trade - 10.11am 08/11/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.